(S (NP-SBJ (NN Gangliosides)) (VP (VBP suppress) (NP (NP (NN tumor) (NN necrosis) (NN factor) (NN production)) (PP (IN in) (NP (JJ human) (NNS monocytes))))) (. .))
(S (NP-SBJ (ADJP-COOD (CC Both) (ADJP (JJ normal)) (CC and) (ADJP (JJ malignant))) (NNS cells)) (VP (VBP contain) (NP (NNS gangliosides)) (PP (IN as) (NP (NP (JJ important) (NN cell) (NN membrane) (NNS constituents)) (SBAR (WHNP-48 (WDT that)) (, ,) (S (PP-TMP (IN after) (S (NP-SBJ-50 (-NONE- *-49)) (VP (VBG being) (VP (VBN shed) (NP (-NONE- *-50)))))) (, ,) (NP-SBJ-49 (-NONE- *T*-48)) (VP (MD may) (VP (VB influence) (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (JJ immune) (NN system))))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN studied) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NNS gangliosides))) (PP (IN on) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN TNF))) (PP-COOD (PP (IN in) (NP (NN blood) (NNS monocytes))) (CC and) (PP (IN in) (NP (DT the) (JJ monocytic) (NN cell) (NN line) (NN Mono) (NN Mac) (CD 6))))))))) (. .))
(S (SBAR-ADV (IN Although) (S (PP (IN under) (NP (JJ standard) (NN culture) (NNS conditions))) (, ,) (NP-SBJ (NP (JJ bovine) (NN brain) (NNS gangliosides)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 100) (NNS (ml micrograms)))) (-RRB- -RRB-))) (VP-COOD (VP (VBD suppressed) (NP (JJ LPS-stimulated) (NN TNF) (NN production)) (ADVP-107 (RB 5-fold)) (PP-108 (IN in) (NP (NN PBMC)))) (CC and) (VP (ADVP=107 (RB 10-fold)) (PP=108 (IN in) (NP (NN Mono) (NN Mac) (CD 6) (NNS cells))))))) (, ,) (NP-SBJ (NN suppression)) (VP (VBD was) (ADJP-PRD (RBR more) (JJ efficient)) (PP (IN under) (NP (JJ serum-free) (NNS conditions)))) (. .))
(S (S-ADV (NP-SBJ (-NONE- *)) (VP (VBG Looking) (PP (IN at) (NP (ADJP (RB highly) (VBN purified)) (NNS gangliosides))))) (, ,) (NP-SBJ-COOD-51 (NP (NN GD3)) (, ,) (NP (NN GD1a)) (, ,) (NP (NN GM3)) (, ,) (NP (NN GM2)) (, ,) (CC and) (NP (NN GM1))) (VP (VBD were) (ADJP-PRD (DT all) (JJ effective)) (PP (IN in) (S (NP-SBJ (-NONE- *-51)) (VP (VBG reducing) (NP (NP (NN TNF) (NN production)) (PP-COOD (PP (IN in) (NP (NN PBMC))) (, ,) (CC and) (PP (IN in) (NP (NN Mono) (NN Mac) (CD 6)))) (PP (IN by) (NP (NN factor) (NP-COOD (NP (CD 10)) (TO to) (NP (CD 50)))))))))) (. .))
(S (NP-SBJ-52 (DT The) (JJ suppressive) (NN activity)) (VP (VBD was) (VP (VBN lost) (NP-53 (-NONE- *-52)) (PP (IN in) (NP (NNS molecules))) (, ,) (S (NP-SBJ (-NONE- *-53)) (VP (VBG lacking) (NP-COOD (NP (DT the) (NN sugar) (NN moiety)) (CC or) (NP (DT the) (NN lipid) (NN moiety))))))) (. .))
(S (NP-SBJ-54 (NNS Gangliosides)) (VP (VBP appear) (S (NP-SBJ (-NONE- *-54)) (VP (TO to) (VP (VB act) (PP (IN at) (NP (NP (DT an) (JJ early) (NN step)) (PP (IN of) (NP (NN activation))) (SBAR (WHPP-109 (IN in) (WHNP (IN that))) (S-COOD (S (NP-SBJ-55 (NN TNF) (NNS transcripts)) (VP (VBD were) (VP (VBN reduced) (NP (-NONE- *-55)) (PP (-NONE- *T*-109))))) (CC and) (S (NP-SBJ-56 (NP (DT the) (NN mobilization)) (PP (IN of) (NP (DT the) (JJ nuclear) (NN factor) (NN kappa) (NN B)))) (VP (VBD was) (VP (VBN blocked) (NP (-NONE- *-56)) (PP (-NONE- *T*-109))))))))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (PP (IN in) (NP (NN time) (NNS kinetics))) (, ,) (NP-SBJ (NNS gangliosides)) (VP (VBD were) (ADJP-PRD (JJ effective)) (UCP-TMP-COOD (PP (IN for) (NP (NP (QP (RB up) (TO to) (CD 30)) (NN min)) (PP-TMP (IN after) (NP (NP (NN addition)) (PP (IN of) (NP (NN LPS))))))) (, ,) (CC but) (ADVP (RB not) (RB thereafter)))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ-57 (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (DT the) (NN CD14) (NN Ag)) (, ,) (NP (NP (DT a) (NN receptor) (NN molecule)) (PP (IN for) (NP (NN LPS-LPS) (NN binding) (NN protein) (NNS complexes)))) (, ,)))) (VP (VBD was) (VP (JJ unaffected) (NP (-NONE- *-57)) (PP (IN by) (NP-LGS (NNS gangliosides))))) (. .))
(S (ADVP (RB Finally)) (, ,) (SBAR-TMP (WHADVP-58 (WRB when)) (S (NP-SBJ (-NONE- *)) (VP (VBG using) (NP-COOD (NP (FW Staphylococcus) (FW aureus)) (CC or) (NP (NN platelet) (NN activating) (NN factor))) (PP (IN as) (NP (DT a) (NN stimulus))) (ADVP (-NONE- *T*-58))))) (, ,) (NP-SBJ-59 (NNS gangliosides)) (VP (VBD were) (ADJP-PRD (JJ able) (S (NP-SBJ (-NONE- *-59)) (VP (TO to) (VP (VB suppress) (NP (NP (NN TNF) (NN production)) (PP (IN in) (NP (NN Mono) (NN Mac) (CD 6) (NNS cells)))) (PP (IN by) (NP (NN factor) (NP-COOD (NP (CD 5)) (TO to) (NP (CD 10))))) (, ,) (PP (RB as) (ADVP (RB well)))))))) (. .))
(S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP-SBJ (NP (ADJP (NN phorbol) (JJ ester-induced)) (NN production)) (PP (IN of) (NP (NN O2-)))) (VP (VBD was) (ADJP-PRD (JJ similar)) (PP (IN in) (NP (NP (NNS cells)) (VP (VBN treated) (NP (-NONE- *)) (PP (PP-COOD (PP (IN with) (NP (-NONE- *RNR*-60))) (CC and) (PP (IN without) (NP (-NONE- *RNR*-60)))) (NP-60 (NNS gangliosides))))))) (. .))
(S (S-ADV (NP-SBJ-61 (-NONE- *)) (VP (VBN Taken) (NP (-NONE- *-61)) (ADVP (RB together)))) (, ,) (NP-SBJ (PRP$ our) (NNS data)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ-62 (NP (NN TNF) (NN gene) (NN expression)) (PP (IN in) (NP (NNS monocytes))) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP (NP (JJ different) (NNS types)) (PP (IN of) (NP (NNS stimuli))))))) (VP (MD can) (VP (VB be) (VP (VBN blocked) (NP (-NONE- *-62)) (PP (IN by) (NP-LGS (NNS gangliosides))) (PP-TMP (IN at) (NP (NP (DT an) (JJ early) (NN step)) (PP (IN of) (NP (JJ signal) (NN transduction))))))))))) (. .))
